Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Phuphanich

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cancer Treatment Reports|November 1, 1986
Phase II study of combined carmustine, 5-fluorouracil, hydroxyurea, and 6-mercaptopurine (BFHM) for the treatment of malignant gliomasV A Levin, S Phuphanich, H C Liu, et al.
Neuro-Oncology|September 29, 2011
Phase I trial of sorafenib in patients with recurrent or progressive malignant gliomaL B Nabors, J G Supko, M Rosenfeld, et al.
Magnetic Resonance Imaging|January 1, 1995
Comparison of supervised MRI segmentation methods for tumor volume determination during therapyM Vaidyanathan, L P Clarke, R P Velthuizen, et al.
The Journal of Pediatric Endocrinology|April 1, 1993
Neurotransmitter control of growth hormone secretion in children after cranial radiation therapyE V Jorgensen, I D Schwartz, E Hvizdala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumorsM J Glantz, K A Jaeckle, M C Chamberlain, et al.
Journal of Neuro-Oncology|October 19, 2015
A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patientsJ J Raizer, P Giglio, J Hu, et al.
British Journal of Cancer|February 13, 2001
Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabineK A Jaeckle, S Phuphanich, M J Bent, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cancer Treatment Reports|November 1, 1986
Phase II study of combined carmustine, 5-fluorouracil, hydroxyurea, and 6-mercaptopurine (BFHM) for the treatment of malignant gliomasV A Levin, S Phuphanich, H C Liu, et al.
Neuro-Oncology|September 29, 2011
Phase I trial of sorafenib in patients with recurrent or progressive malignant gliomaL B Nabors, J G Supko, M Rosenfeld, et al.
Magnetic Resonance Imaging|January 1, 1995
Comparison of supervised MRI segmentation methods for tumor volume determination during therapyM Vaidyanathan, L P Clarke, R P Velthuizen, et al.
The Journal of Pediatric Endocrinology|April 1, 1993
Neurotransmitter control of growth hormone secretion in children after cranial radiation therapyE V Jorgensen, I D Schwartz, E Hvizdala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumorsM J Glantz, K A Jaeckle, M C Chamberlain, et al.
Journal of Neuro-Oncology|October 19, 2015
A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patientsJ J Raizer, P Giglio, J Hu, et al.
British Journal of Cancer|February 13, 2001
Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabineK A Jaeckle, S Phuphanich, M J Bent, et al.
Pageof 3